33OAnti-MUC1 CAR-T cells combined with PD-1 knockout engineered T cells for patients with non-small cell lung cancer (NSCLC): A pilot study. (17th December 2018) - Chen, S; Lin, Y; Zhong, S; An, H; Lu, Y; Yin, M; Liang, W; McGowan, E M